ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression

• Egile Nagusiak: Yuanfei Deng (Egilea), Cuifu Yu (Egilea), Lushi Chen (Egilea), Xin Zhang (Egilea), Qiucheng Lei (Egilea), Qing Liu (Egilea), Gengxi Cai (Egilea), Fang Liu (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hepatocellular carcinoma (HCC) is the most commonly diagnosed liver cancer with limited treatment options and extremely poor prognosis worldwide. Recently, the proteolysis targeting chimeras (PROTACs), which aim to induce proteasome-mediated degradation of interesting proteins via recruiting E3 liga...